STAT

NOVEMBER 26, 2024

As a physician, I was taught to appreciate the clinical importance of human touch for our physical and mental health. As a human being, I worry about its loss. And as a dermatologist, I know what that loss may mean for the loneliest and most vulnerable among us.  Scientific studies prove that human touch — whether it be a quick hug, holding a baby, or a professional massage — is important to our mental and physical well-being.

Immunity 290

Immunity Immunization 290

PharmaVoice

NOVEMBER 26, 2024

Pharma companies looking to get a break from the FTC under a new administration may be out of luck.

185

185

STAT

NOVEMBER 26, 2024

The Office for Civil Rights is not checking whether health care providers and other people who handle Americans’ sensitive data are complying with federal health privacy law, a new report from the U.S. Department of Health and Human Services Office of the Inspector General has found.  The Office of Civil Rights, or OCR is in charge of enforcing HIPAA, the law that protects patients’ data from cyberattackers and other unauthorized parties.

HIPAA 276

HIPAA 276

PharmaVoice

NOVEMBER 26, 2024

Stoke Therapeutics is entering phase 3 with its RNA medicine designed to treat a rare epileptic condition.

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 26, 2024

New data from a mid-stage study of an Amgen obesity drug showed that it helped participants lose a substantial amount of weight, but questions about how competitive it could be appear to be shaping the response to the news, with the company’s share price falling on the announcement.  Amgen said Tuesday that that its drug, MariTide , led to an average of roughly 20% weight loss over a year in the Phase 2 study in participants who had obesity or who were overweight without type 2 diabe

Diabetes 273

Diabetes Drug Development 273

The Pharmacist

NOVEMBER 26, 2024

Pharmacists have been urged to continue to promote the importance of folic acid supplementations following news that it will be added to non-wholemeal flour from the end of 2026. The UK’s chief nursing officers, chief midwifery officers and chief medical officers have written to health professionals warning of the ‘risk’ that some women will stop […] The post Pharmacists must continue promotion of folic acid after fortification of flour appeared first on The Pharmacist.

102

102

European Pharmaceutical Review

NOVEMBER 26, 2024

Glucagon-like peptide-1 (GLP-1) receptor agonists have shown to provide meaningful benefits in chronic kidney disease (CKD) and individuals with and without diabetes. This based on the largest, most comprehensive analysis of GLP-1 antagonists on kidney and cardiovascular outcomes. While GLP-1 receptor agonists have shown benefit for type 2 diabetes, obesity and cardiovascular disease, its impact as a treatment in chronic kidney disease is not as clear, the researchers explained.

Diabetes 96

Diabetes 96

STAT

NOVEMBER 26, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. How FDA categories may keep AI from relieving clinician burnout In a counterintuitive result, using AI did not reduce radiologists’ burnout, a recent JAMA Network Open study of over 6,700 radiologists in China found.

265

265

Express Pharma

NOVEMBER 26, 2024

Ever-increasing drug discovery and development timelines are a multiscale issue causing delays in patient access to medicines and increasing costs for pharmaceutical companies. Digital transformation could streamline the process, accelerate innovation, and improve efficiency, according to a survey conducted by GlobalData In a recent GlobalData’s survey, “Digital Transformation and Emerging Technologies in the Healthcare Industry – 2024”, 82 per cent of surveyed pharmaceutical industry profession

Drug Development 96

Drug Development Pharmaceutical Companies Pharmaceutical Companies 96

STAT

NOVEMBER 26, 2024

LONDON — An experimental cancer treatment from Roche failed to improve survival in a major lung cancer study, the company said Tuesday, a result that will further stoke doubts about the drug’s target. In a short statement, Roche said that a combination of the drug, called tiragolumab, with its existing medicine Tecentriq did not outperform Tecentriq alone on the study’s primary endpoint of overall survival.

256

256

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Drug Patent Watch

NOVEMBER 26, 2024

In the ever-evolving landscape of pharmaceutical research and development, drug repurposing has emerged as a promising strategy to bring new treatments to patients more quickly and cost-effectively. However, navigating the complex web of intellectual property rights and regulatory considerations in this field can be challenging.

94

94

STAT

NOVEMBER 26, 2024

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases in the muscle, nervous system, and lung.  In addition to the upfront payment, Sarepta will also make a $325 million investment in Arrowhead, pay out $50 million a year for the next five years, and promise $300 million in “near-term” milestone payments related to clinical trial enrollment.

208

208

Express Pharma

NOVEMBER 26, 2024

The 17th edition of CPHI & PMEC India, organised by Informa Markets in India opened its doors at the India Expo Centre, Greater Noida, Delhi-NCR, showcasing the robust potential of India’s pharmaceutical industry. With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare.

Packaging 83

Packaging Biosimilars Pharmaceutical Manufacturing Dosage 83

STAT

NOVEMBER 26, 2024

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These medications have made tens of billions of dollars for drugmakers and have made their way into the public consciousness in a remarkable way.  Almost three-quarters of adults in the U.S. are overweight or obese, and obesity can lead to a litany of health complications, including heart disease, joint pain, and cancer.

Drug Pricing 194

Drug Pricing 194

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Express Pharma

NOVEMBER 26, 2024

Freudenberg, a worldwide technology business based in Germany, will attend CPhI & PMEC India 2024 on November 26-28, 2024. Freudenberg is a trusted supplier of biopharmaceutical devices, systems, high-performance sealing, and filtering solutions, and services to pharmaceutical and healthcare industries in India. The booth, located in Hall No. 15 – No.

76

76

STAT

NOVEMBER 26, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Happy Tuesday! Adam Feuerstein, here, filling in for your regular Readout correspondents.

Drug Pricing 192

Drug Pricing Drug Development 192

pharmaphorum

NOVEMBER 26, 2024

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline.

105

105

STAT

NOVEMBER 26, 2024

LONDON — Policymakers and scientific groups need to specify guidelines for the burgeoning field that uses stem cells to mimic aspects of embryonic development, including by establishing certain red lines on research, an influential U.K. bioethics group said Wednesday in a new report.  Specifically, the report from the Nuffield Council on Bioethics says that researchers should not use these stem cell-based embryo models to try to start a pregnancy in a person or animal, and should not

Bioethics 182

Bioethics 182

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

NOVEMBER 26, 2024

Roche has upgraded its partnership with off-the-shelf CAR-T therapy specialist Poseida to a $1 billion-plus takeover bid.

92

92

Pharmaceutical Technology

NOVEMBER 26, 2024

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Vaccines 93

Vaccines 93

pharmaphorum

NOVEMBER 26, 2024

ZENITH trial of MSD's Winrevair in PAH could add further momentum to an already impressive launch.

97

97

Express Pharma

NOVEMBER 26, 2024

The US Food and Drug Administration has approved BridgeBio’s drug for a rare and deadly heart condition, the company said on Friday, making it the first new treatment in a market dominated by Pfizer’s blockbuster Vyndaqel. The oral drug, branded as Attruby, was approved to treat adult patients with transthyretin amyloid cardiomyopathy (ATTR-CM), in which faulty transthyretin proteins accumulate in the heart and can cause the organ to fail.

Dosage 63

Dosage Labelling 63

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

NOVEMBER 26, 2024

Outgoing US President Joe Biden has proposed a dramatic expansion of Medicare coverage of obesity drugs, but will the plan see the light of day?

78

78

The Pharmacist

NOVEMBER 26, 2024

Medicines shortages are increasing professional tensions between pharmacy teams and other healthcare providers, a new report from the Royal Pharmaceutical Society (RPS) has warned. In both primary and secondary care settings, medicines shortages are 'often viewed as a pharmacy issue by healthcare teams with little appreciation of the wider context in which shortages occur', the […] The post Medicines shortages 'increasing tensions' between GPs and pharmacists appeared first on Th

62

62

BioPharma Dive

NOVEMBER 26, 2024

The brain drug developer is letting go of around 41 of its 238 employees, in a move the company says will help “align resources” with its strategic priorities.

Drug Development 62

Drug Development 62

pharmaphorum

NOVEMBER 26, 2024

Discover the revolutionary impact of generative artificial intelligence (GenAI) on drug safety in pharmacovigilance. Learn how this cutting-edge technology is transforming the industry.

59

59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

NOVEMBER 26, 2024

The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing share price on Monday.

62

62

FDA Law Blog: Biosimilars

NOVEMBER 26, 2024

By Larry K. Houck — Last May the Department of Justice (“DOJ”) and the Drug Enforcement Administration (“DEA”) issued a Notice of Proposed Rulemaking (“NPRM”) to transfer marijuana from schedule I of the Controlled Substances Act (“CSA”) to schedule III. Schedules of Controlled Substances: Rescheduling of Marijuana, 89 Fed. Reg. 44,597 (May 21, 2024).

Controlled Substances 57

Controlled Substances 57

BioPharma Dive

NOVEMBER 26, 2024

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound.

62

62

epicur

NOVEMBER 26, 2024

Our sister division, Stokes Pharmacy, and the Bova Group have almost parallel stories—pharmacies with retail roots that expanded into compounding to better serve a larger audience with the highest quality medications possible. Both organizations have made a significant impact in the countries they serve—Stokes in the US and Bova in Australia and the United Kingdom—and they’ve both raised the bar for quality of care in veterinary medicine.

Compounding 52

Compounding Compounding Pharmacies Communication Hospitals 52

BioPharma Dive

NOVEMBER 26, 2024

Long-awaited results released Tuesday showed adding tiragolumab to Roche's immunotherapy Tecentriq did not extend survival in a closely followed Phase 3 study called SKYSCRAPER-01.

57

57